We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $61.5B
1-Year Est. Return 30.7%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$28.9B
AUM Growth
+$2.95B
Cap. Flow
+$675M
Cap. Flow %
2.33%
Top 10 Hldgs %
19.23%
Holding
1,870
New
126
Increased
733
Reduced
826
Closed
117

Top Buys

Rank Stock Value
1
WMB icon
Williams Companies
WMB
+$105M
2
GM icon
General Motors
GM
+$65.4M
3
PINC
Premier
PINC
+$63.9M
4
DVN icon
Devon Energy
DVN
+$61.7M
5
MS icon
Morgan Stanley
MS
+$51.5M

Sector Composition

Rank Sector Weight
1 Healthcare 17.24%
2 Consumer Staples 11.88%
3 Energy 9.92%
4 Financials 9.14%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BP icon
26
BP
BP
$112B
$209M 0.72%
5,248,143
+413,802
+9% +$15.4M
DXCM icon
27
DexCom
DXCM
$29B
$208M 0.72%
23,494,528
-5,096,420
-18% -$40.3M
ESRX
28
DELISTED
Express Scripts Holding Company
ESRX
$204M 0.71%
2,905,385
-22,491
-0.8% -$1.47M
WFC icon
29
Wells Fargo
WFC
$254B
$198M 0.68%
4,355,711
-87,377
-2% -$3.77M
RDS.B
30
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$190M 0.66%
2,523,727
+72,481
+3% +$5.1M
JPM icon
31
JPMorgan Chase
JPM
$916B
$188M 0.65%
3,218,359
-741,717
-19% -$40.6M
LLY icon
32
Eli Lilly
LLY
$1.08T
$187M 0.65%
3,670,757
+423,004
+13% +$21.2M
GSK icon
33
GSK
GSK
$107B
$170M 0.59%
2,544,232
+72,704
+3% +$4.71M
WMB icon
34
Williams Companies
WMB
$85.8B
$169M 0.59%
4,389,746
+2,910,171
+197% +$105M
SLXP
35
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$163M 0.56%
1,806,977
-10,304
-0.6% -$822K
CBST
36
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$159M 0.55%
2,306,435
-51,261
-2% -$3.32M
AEP icon
37
American Electric Power
AEP
$70.4B
$158M 0.55%
3,387,809
-32,753
-1% -$1.51M
HAL icon
38
Halliburton
HAL
$26.1B
$152M 0.53%
3,004,864
-248,353
-8% -$12.8M
WHR icon
39
Whirlpool
WHR
$2.49B
$148M 0.51%
946,045
-16,786
-2% -$2.46M
PG icon
40
Procter & Gamble
PG
$340B
$147M 0.51%
1,811,493
+8,381
+0.5% +$683K
ALKS icon
41
Alkermes
ALKS
$8.11B
$146M 0.51%
3,598,553
-133,303
-4% -$4.92M
PEP icon
42
PepsiCo
PEP
$196B
$146M 0.5%
1,755,738
+20,005
+1% +$1.66M
BMY icon
43
Bristol-Myers Squibb
BMY
$129B
$140M 0.49%
2,638,687
-117,268
-4% -$5.97M
GILD icon
44
Gilead Sciences
GILD
$165B
$132M 0.46%
1,758,201
-183,016
-9% -$12.7M
CVS icon
45
CVS Health
CVS
$135B
$120M 0.41%
1,674,446
-83,408
-5% -$5.36M
DYAX
46
DELISTED
DYAX CORPORATION
DYAX
$118M 0.41%
15,728,937
-2,800,371
-15% -$21.3M
BIIB icon
47
Biogen
BIIB
$30.9B
$118M 0.41%
423,186
-12,705
-3% -$3.29M
HIG icon
48
Hartford Financial Services
HIG
$39.9B
$115M 0.4%
3,165,564
-301,172
-9% -$10.4M
FBIN icon
49
Fortune Brands Innovations
FBIN
$5.86B
$110M 0.38%
2,817,044
-95,020
-3% -$3.43M
CBI
50
DELISTED
Chicago Bridge & Iron Nv
CBI
$107M 0.37%
1,292,600
-22,600
-2% -$1.71M

Similar funds

Federated Hermes's Q4 2013 Portfolio in Review

As of Q4 2013, Federated Hermes held 1,870 positions worth $28.9B, up 11% from $25.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Federated Hermes's Q4 2013 filing shows 126 new, 733 increased, 826 reduced and 117 closed positions. Its largest new stake was Premier: 1,935,888 shares worth $71.2M. The largest sale was Johnson & Johnson, an estimated $112M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Energy.

  • Federated Hermes's largest Q4 2013 buy was Premier: 1,935,888 shares worth $71.2M.
  • Federated Hermes added most to Williams Companies in Q4 2013, an estimated $105M increase.
  • Federated Hermes's biggest Q4 2013 reduction was Johnson & Johnson, cutting an estimated $112M.
  • Federated Hermes fully exited Cobalt International Energy, Inc in Q4 2013, selling an estimated $68.6M.
  • Federated Hermes's ten largest holdings make up 19% of its $28.9B portfolio in Q4 2013.
  • Federated Hermes opened 126 new positions and closed 117 in Q4 2013.
  • Federated Hermes's portfolio value rose 11% quarter-over-quarter to $28.9B.

Based on Federated Hermes's 13F filing for Q4 2013, filed 11 Feb 2014.